AGCO vs TTEK

AGCO's financial health is stable but not strong, with a Piotroski F-Score of 4/9 indicating borderline performance across key metrics. The absence of an Altman Z-Score prevents a full distress risk assessment, though the Debt/Equity ratio of 0.63 and Current Ratio of 1.58 suggest manageable leverage and liquidity. Valuation appears reasonable relative to peers with a P/E of 22.76 versus sector average of 50.86, yet revenue decline and weak technicals temper optimism. Despite explosive recent earnings growth, inconsistent quarterly beats and negative insider activity raise caution.

TTEK demonstrates stable financial health with a Piotroski F-Score of 6/9 and a strong ROE of 19.92%. While the company possesses an exceptional track record of beating earnings estimates over 25 consecutive quarters, current revenue growth is a significant concern at -13.40% YoY. The stock trades at a steep premium to its Graham Number ($14.55) but remains below its growth-based intrinsic value ($39.23). Bearish technical trends and insider selling currently offset the positive analyst consensus and fundamental stability.